🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Low-Risk Prostate Cancer

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site📍 Zamość Affidea Nu-med Center of Oncological DIagnostics and Therapy · Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachythe… Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer NCT07260435Phase 326 sites📍 Alkmaar📍 Amersfoort📍 Amsterdam Nick Beije · Tests: ADT plus only 12 months of ARPI, ADT plus continued ARPI Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance NCT07168616n/a10 sites📍 Istanbul📍 Ankara📍 Diyarbakır Istanbul University - Cerrahpasa · Tests: Ga-68 PSMA11 PET/CT Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance NCT06866041NA1 site📍 Milan Università Vita-Salute San Raffaele · Tests: mpMRI-targeted confirmatory biopsy Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer NCT06145633Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Biopsy Procedure, Biospecimen Collection, Bone Scan, Computed Tomography, Fludeoxyglucose F-18 Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer NCT07526675NA1 site📍 Banhā Benha University · Tests: Bioblation Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer NCT03789253n/a1 site📍 Taipei National Taiwan University Hospital Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance NCT06733350Phase 41 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging, Patient Observation, Questionnaire Administrati… A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer NCT07241416Phase 31 site📍 Beijing Jiangsu HengRui Medicine Co., Ltd. · Tests: Rezvilutamide Tablets, Enzalutamide Soft Capsules Safety and Efficacy of Two-step Radical Prostatectomy NCT05722392n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Two-step Radical Prostatectomy Active Surveillance for Low Risk Prostate Cancer NCT04146077n/a1 site📍 Moscow I.M. Sechenov First Moscow State Medical University Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer NCT07562438Phase 21 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: 177Lu-P17-088 Spanish Urological Association Registry of Patients on Active Surveillance NCT02865330n/a1 site📍 Valencia Fundación Instituto Valenciano de Oncología · Tests: Registry Active Surveillance for Cancer of the Prostate (ASCaP) NCT00949819n/a1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Active surveillance INSPIRE: INnovative SABR for Prostate Cancer All IREland NCT07552168Phase 24 sites📍 Dublin📍 Cork📍 Waterford Cancer Trials Ireland · Tests: Next generation Stereotactic Ablative Radiotherapy (SABR) Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial NCT07650240Phase 21 site📍 Rochester Mayo Clinic · Tests: Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate, Lutetium Lu 177 Vipivotide Tetraxetan, Prednisone Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy NCT03830788NA20 sites📍 Albi📍 Angers📍 Bordeaux Center Eugene Marquis · Tests: Radiation by brachytherapy, Radiation by SBRT PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer NCT07426094Phase 2, Phase 31 site📍 Zamość Affidea Nu-med Center of Oncological DIagnostics and Therapy · Tests: Ultrahypofractionated Whole-Pelvis Radiotherapy, SBRT-Based Prostate Radiotherapy (No Boost), Ablative Prostate Boost, … EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM) NCT06482489n/a1 site📍 Lausanne University of Lausanne Hospitals · Tests: Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany). Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer NCT06200974n/a1 site📍 Kelowna British Columbia Cancer Agency · Tests: High dose rate prostate brachytherapy Tractography-Guided Nerve-Sparing in Prostate Cancer NCT07847385NA1 site📍 Geneva Massimo Valerio · Tests: Prostate Tractography for Nerve-Sparing Low-Count Quantitative SPECT for Men Treated With Radium-223 NCT07221825NA1 site📍 St Louis Washington University School of Medicine · Tests: Low-count quantitative single-photon emission computed tomography imaging Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain NCT05868668NA1 site📍 Cleveland The Cleveland Clinic · Tests: Focused shockwave, Radial wave, Sham treatment MRI Guided Focal Laser Ablation of Prostate Cancer NCT03650595NA1 site📍 Toronto University Health Network, Toronto · Tests: The TRANBERGCLS|Thermal Therapy First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer NCT07608848EARLY Phase 11 site📍 Perth Integrated Haematology and Oncology Network · Tests: [177Lu]Lu-DOTA-STR-17126, [68Ga]Ga-DOTA-STR-17126 Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers NCT06717711Phase 32 sites📍 Rome📍 Naples Regina Elena Cancer Institute · Tests: Low-intensity Extracorporeal Shock Wave Therapy (LiESWT), PDE5 inhibitor (tadalafil) Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728Phase 23 sites📍 Abbotsford📍 Northcote📍 Leederville Psyence Australia Pty Ltd · Tests: Psilocybin therapy Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study. NCT06784986Phase 42 sites📍 Salvador📍 Salvador Brazilian Institute of Robotic Surgery · Tests: The Conventional Insufflation System, AirSeal® System A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer NCT06347705Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: 2141-V11 Antibody
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy